Information relating to the compensation elements of Mr. Aymeric Le CHATELIER, interim Chief Executive Officer from 1st January 2020 to 30 June 2020

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023